A comprehensive review of the genetic basis of cleft lip and palate

Journal of Oral and Maxillofacial Pathology

Volumn 16, Issue 1, 2012, Pages 64-72

  Kohli, Sarvraj Singh ^a   Kohli, Virinder Singh ^a  

^a Hitkarini Dental College and Hospital   (India)

Author keywords

Cleft lip; cleft palate; etiology; genetics

Indexed keywords

EID: 84857870239     PISSN: 0973029X     EISSN: 1998393X     Source Type: Journal    
DOI: 10.4103/0973-029X.92976     Document Type: Review

References (97)

1. Online Mendelian Inheritance in Man. National Library of Medicine website: Available from: http://www.ncbi.nlm.nih.gov/omim/. [Last accessed 2011 Jan 3].
2. Stoll C, Alembik Y, Dott B, Roth MP. Associated malformations in cases with oral clefts. Cleft Palate Craniofac J 2000;37:41-7. (Pubitemid 30065017)
3. Stanier P, Forbes SA, Arnason A, Bjornsson A, Sveinbjornsdottir E, Williamson R, et al. The localization of a gene causing X-linked cleft palate and ankyloglossia (CPX) in an Icelandic kindred is between DXS326 and DXYS1X. Genomics 1993;17:549-55. (Pubitemid 23282805)
4. Braybrook C, Doudney K, Marçano AC, Arnason A, Bjornsson A, Patton MA, et al. The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet 2001;29:179-83. (Pubitemid 32952655)
5. Prescott NJ, Lees MM, Winter RM, Malcolm S. Identification of susceptibility loci for nonsyndromic cleft lip with or without cleft palate in a two stage genome scan of affected sib-pairs. Hum Genet 2000;106:345-50. (Pubitemid 30201284)
6. Suzuki K, Hu D, Bustos T, Zlotogora J, Richieri-Costa A, Helms JA, et al. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet 2000;25:427-30. (Pubitemid 32983436)
7. Takahashi K, Nakanishi H, Miyahara M, Mandai K, Satoh K, Satoh A, et al. Nectin/PRR: An immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol 1999;145:539-49. (Pubitemid 29215718)
8. Sözen MA, Suzuki K, Tolarova MM, Bustos T, Fernández Iglesias JE, Spritz RA. Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet 2001;29:141-2. (Pubitemid 32952649)
9. Burdick AB. Genetic epidemiology and control of genetic expression in van der Woude syndrome. J Craniofac Genet Dev Biol Suppl 1986;2:99-105. (Pubitemid 17208042)
10. Bixler D, Poland C, Nance WE. Phenotypic variation in the popliteal pterygium syndrome. Clin Genet 1973;4:220-8.
11. Murray JC, Nishimura DY, Buetow KH, Ardinger HH, Spence MA, Sparkes RS, et al. Linkage of an autosomal dominant clefting syndrome (Van der Woude) to loci on chromosome Iq. Am J Hum Genet 1990;46:486-91.
12. Lees MM, Winter RM, Malcolm S, Saal HM, Chitty L. Popliteal pterygium syndrome: A clinical study of three families and report of linkage to the Van der Woude syndrome locus on 1q32. J Med Genet 1999;36:888-92. (Pubitemid 30003844)
13. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 2002;32:285-9.
14. Houdayer C, Bonaïti-Pellié C, Erguy C, Soupre V, Dondon MG, Bürglen L, et al. Possible relationship between the van der Woude syndrome (vWS) locus and nonsyndromic cleft lip with or without cleft palate (NSCL/P). Am J Med Genet 2001;104:86-92. (Pubitemid 33020157)
15. Ardinger HH, Buetow KH, Bell GI, Bardach J, VanDemark DR, Murray JC. Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet 1989;45:348-53. (Pubitemid 19231314)
16. Machida J, Yoshiura K, Funkhauser CD, Natsume N, Kawai T, Murray JC. Transforming growth factor-alpha (TGFA): Genomic structure, boundary sequences, and mutation analysis in nonsyndromic cleft lip/palate and cleft palate only. Genomics 1999;61:237-42.
17. Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, et al. Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: Indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 1995;141:629-36.
18. Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996;58:551-61. (Pubitemid 26062486)
19. Shaw GM, Wasserman CR, Murray JC, Lammer EJ. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J 1998;35:366-70. (Pubitemid 28326187)
20. Satokata I, Maas R. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 1994;6:348-56. (Pubitemid 24190017)
21. Vastardis H, Karimbux N, Guthua SW, Seidman JG, Seidman CE. A human MSX1 homeodomain missense mutation causes selective tooth agenesis. Nat Genet 1996;13:417-21. (Pubitemid 26256614)
22. van den Boogaard MJ, Dorland M, Beemer FA, van Amstel HK. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 2000;24:342-3. (Pubitemid 30187429)
23. Jezewski PA, Vieira AR, Nishimura C, Ludwig B, Johnson M, O'Brien SE, et al. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet 2003;40:399-407. (Pubitemid 36760656)
24. Jugessur A, Lie RT, Wilcox AJ, Murray JC, Taylor JA, Saugstad OD, et al. Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: A case-parent triad analysis. Genet Epidemiol 2003;24:230-9. (Pubitemid 36444188)
25. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
26. Prescott NJ, Winter RM, Malcolm S. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J Med Genet 2002;39:368-9. (Pubitemid 34526360)
27. van Rooij IA, Vermeij-Keers C, Kluijtmans LA, Ocké MC, Zielhuis GA, Goorhuis-Brouwer SM, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003;157:583-91. (Pubitemid 36368528)
28. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 1995;11:409-14. (Pubitemid 3007193)
29. Vieira AR, Orioli IM, Castilla EE, Cooper ME, Marazita ML, Murray JC. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res 2003;82:289-92. (Pubitemid 41766026)
30. Kim MH, Kim HJ, Choi JY, Nahm DS. Transforming growth factor-beta3 gene SfaN1 polymorphism in Korean nonsyndromic cleft lip and palate patients. J Biochem Mol Biol 2003;36:533-7.
31. FitzPatrick DR, Carr IM, McLaren L, Leek JP, Wightman P, Williamson K, et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 2003;12: 2491-501. (Pubitemid 37220413)
32. Beiraghi S, Foroud T, Diouhy S, Bixler D, Conneally PM, Delozier-Blanchet D, et al. Possible localization of a major gene for cleft lip and palate to 4q. Clin Genet 1994;46:255-6. (Pubitemid 24299178)
33. Beiraghi S, Zhou M, Talmadge CB, Went-Sumegi N, Davis JR, Huang D, et al. Identification and characterization of a novel gene disrupted by a pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip. Gene 2003;309:11-21. (Pubitemid 36513857)
34. Yoshiura K, Machida J, Daack-Hirsch S, Patil SR, Ashworth LK, Hecht JT, et al. Characterization of a novel gene disrupted by a balanced chromosomal translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate. Genomics 1998;54:231-40. (Pubitemid 28553632)
35. Stein J, Mulliken JB, Stal S, Gasser DL, Malcolm S, Winter R, et al. Nonsyndromic cleft lip with or without cleft palate: Evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet 1995;57:257-72.
36. Wyszynski DF, Maestri N, McIntosh I, Smith EA, Lewanda AF, Garcia-Delgado C, et al. Evidence for an association between markers on chromosome 19q and nonsyndromic cleft lip with or without cleft palate in two groups of multiplex families. Hum Genet 1997;99:22-6. (Pubitemid 26419848)
37. Eiberg H, Bixler D, Nielsen LS, Conneally PM, Mohr J. Suggestion of linkage of a major locus for nonsyndromic orofacial cleft with F13A and tentative assignment to chromosome 6. Clin Genet 1987;32:129-32. (Pubitemid 17122982)
38. Davies AF, Stephens RJ, Olavesen MG, Heather L, Dixon MJ, Magee A, et al. Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet 1995;4:121-8.
39. Jagomägi T, Nikopensius T, Krjutskov K, Tammekivi V, Viltrop T, Saag M, et al. MTHFR and MSX1 contribute to the risk of nonsyndromic cleft lip/palate. Eur J Oral Sci 2010;118:213-20.
40. Lidral AC, Moreno LM. Progress toward discerning the genetics of cleft lip. Curr Opin Pediatr 2005;17:731-9. (Pubitemid 41689666)
41. Vieira AR, Avila JR, Daack-Hirsch S, Dragan E, Félix TM, Rahimov F, et al. Medical sequencing of candidate genes for non-syndromic cleft lip and palate. PLoS Genet 2005;1:e64.
42. Maestri NE, Beaty TH, Hetmanski J, Smith EA, McIntosh I, Wyszynski DF, et al. Application of transmission disequilibrium tests to non-syndromic oral clefts: Including candidate genes and environmental exposures in the models. Am J Med Genet 1997;73:337-44. (Pubitemid 27509914)
43. Marazita ML, Murray JC, Lidral AC, Arcos-Burgos M, Cooper ME, Goldstein T, et al. Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am J Hum Genet 2004;75:161-73. (Pubitemid 38943861)
44. Gaspar DA, Matioli SR, Pavanello RC, Araújo BC, André M, Steman S, et al. Evidence that BCL3 plays a role in the etiology of nonsyndromic oral clefts in Brazilian families. Genet Epidemiol 2002;23:364-74. (Pubitemid 35416674)
45. Blanco R, Suazo J, Santos JL, Paredes M, Sung H, Carreńo H, et al. Association between 10 microsatellite markers and nonsyndromic cleft lip palate in the Chilean population. Cleft Palate Craniofac J 2004;41:163-7. (Pubitemid 38332683)
46. Park BY, Sull JW, Park JY, Jee SH, Beaty TH. Differential parental transmission of markers in BCL3 among Korean cleft case-parent trios. J Prev Med Public Health 2009;42:1-4.
47. Moreno LM, Arcos-Burgos M, Marazita ML, Krahn K, Maher BS, Cooper ME, et al. Genetic analysis of candidate loci in non-syndromic cleft lip families from Antioquia-Colombia and Ohio. Am J Med Genet Part A 2004;125A:135-44. (Pubitemid 38268844)
48. Wyszynski DF, Wu T. Use of US birth certificate data to estimate the risk of maternal cigarette smoking for oral clefting. Cleft Palate Craniofac J 2002;39:188-92. (Pubitemid 34229540)
49. van Rooij IA, Wegerif MJ, Roelofs HM, Peters WH, Kuijpers-Jagtman AM, Zielhuis GA, et al. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: A gene-environment interaction. Epidemiology 2001;12:502-7. (Pubitemid 32761988)
50. Beaty TH, Hetmanski JB, Zeiger JS, Fan YT, Liang KY, VanderKolk CA, et al. testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol 2002;22:1-11. (Pubitemid 34019888)
51. Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC, Hanson J. Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 1996;54:27-33. (Pubitemid 26395136)
52. Shaw GM, Lammer EJ. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr 1999;134:298-303. (Pubitemid 30417637)
53. Natsume N, Kawai T, Ogi N, Yoshida W. Maternal risk factors in cleft lip and palate: Case control study. Br J Oral Maxillofac Surg 2000;38:23-5. (Pubitemid 30182110)
54. Shaw GM, Nelson V, Carmichael SL, Lammer EJ, Finnell RH, Rosenquist TH. Maternal periconceptional vitamins: Interactions with selected factors and congenital anomalies? Epidemiology 2002;13:625-30. (Pubitemid 44698465)
55. Jugessur A, Lie RT, Wilcox AJ, Murray JC, Taylor JA, Saugstad OD, et al. Cleft palate, transforming growth factor alpha gene variants, and maternal exposures: Assessing gene-environment interactions in case-parent triads. Genet Epidemiol 2003;25:367-74. (Pubitemid 37486885)
56. Wong WY, Eskes TK, Kuijpers-Jagtman AM, Spauwen PH, Steegers EA, Thomas CM, et al. Nonsyndromic orofacial clefts: Association with maternal hyperhomocysteinemia. Teratology 1999;60:253-7. (Pubitemid 30265242)
57. Ray JG, Meier C, Vermeulen MJ, Wyatt PR, Cole DE. Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 2003;143:805-7. (Pubitemid 37510654)
58. Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995;51:71-8.
59. Baxter H, Fraser FC. Production of congenital defects in offspring of female mice treated with cortisone. McGill Med J 1950;19:245-9.
60. Diewert VM, Pratt RM. Cortisone-induced cleft palate in A/J mice: Failure of palatal shelf contact. Teratology 1981;24:149-62. (Pubitemid 12180524)
61. Melnick M, Jaskoll T, Slavkin HC. Corticosteroid-induced cleft lip in mice: A teratologic, topographic, and histologic investigation. Am J Med Genet 1981;10:333-50. (Pubitemid 12251066)
62. Gasser DL, Mele L, Lees DD, Goldman AS. Genes in mice that affect susceptibility to cortisone-induced cleft palate are closely linked to Ir genes on chromosomes 2 and 17. Proc Natl Acad Sci USA 1981;78:3147-50. (Pubitemid 11032006)
63. Gasser DL, Goldner-Sauvé A, Katsumata M, Goldman AS. Restriction fragment length polymorphisms, glucocorticoid receptors, and phenytoin-induced cleft palate in congenic strains of mice with steroid susceptibility differences. J Craniofac Genet Dev Biol 1991;11:366-71.
64. Juriloff DM, Mah DG. The major locus for multifactorial non-syndromic cleft lip maps to mouse chromosome 11. Mamm Genome 1995;6:63-9.
65. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999;86:242-4. (Pubitemid 29465870)
66. Rodriquez-Pinilla E, Martínez-Frías ML. Corticosteroids during pregnancy and oral clefts: A case-control study. Teratology 1998;58:2-5. (Pubitemid 28404243)
67. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
68. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 2003;67:968-70. (Pubitemid 38018036)
69. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007;197:585.e1-7; discussion 683-4.
70. Gorlin R, Cohen M, Levin S. Syndromes of the Head and Neck. Oxford: Oxford University Press; 1990.
71. Saxen I, Saxen L. Association between maternal intake of diazepam and oral clefts. Lancet 1975;2:498.
72. Safra MJ, Oakley GP Jr. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975;2:478-80.
73. Czeizel A. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol 1988;1:183-8.
74. Durner M, Greenberg DA, Delgado-Escueta AV. Is there a genetic relationship between epilepsy and birth defects? Neurology 1992;42(4 Suppl 5):63-7.
75. Chang CC, Tsai F, Yang CC. Prenatal Diagnosis of Apert's Syndrome. Prenat Diag 1998;18:621-5
76. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, et al. Aperts syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9:165-72.
77. Slaney SF, Oldridge M, Hurst JA, Moriss-Kay GM, Hall CM, Poole MD, et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 1996;58:923-32. (Pubitemid 26115163)
78. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997;60:555-64. (Pubitemid 27097603)
79. Reardon W, Wilkes D, Rutland P, Pulleyn LJ, Malcolm S, Dean JC, et al. Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J Med Genet 1997;34:632-6. (Pubitemid 27356879)
80. Rollnick BR. Germinal mosaicism in Crouzon syndrome. Clin Genet 1988;33:145-50. (Pubitemid 18068411)
81. Kreiborg S, Cohen MM Jr. Germinal mosaicism in Crouzon syndrome. Hum Genet 1990;84:487-8. (Pubitemid 20129501)
82. Keegan CE, Mulliken JB, Wu BL, Korf BR. Townes-Brocks syndrome versus expanded spectrum hemifacial microsomia: Review of eight patients and further evidence of a "hot spot" for mutation in the SALL1 gene. Genet Med 2001;3:310-3.
83. Kelberman D, Tyson J, Chandler DC, McInerney AM, Slee J, Albert D, et al. Hemifacial microsomia: Progress in understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001;109:638-45. (Pubitemid 34051418)
84. Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras. Proc Natl Acad Sci USA 1996;93:7894-9.
85. Preston RA, Post JC, Keats BJ, Aston CE, Ferrell RE, Priest J, et al. A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nat Genet 1994;7:149-53. (Pubitemid 24174652)
86. Burck U. Genetic aspects of hemifacial microsomia. Hum Genet 1983;64:291-6.
87. Kelberman D, Tyson J, Chandler DC, McInerney AM, Slee J, Albert D, et al. Hemifacial Microsomia progress in understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001;109:638-45. (Pubitemid 34051418)
88. Thomas P. Goldenhar syndrome and Hemifacial microsomia: Observation on three patients. Europ J Pediat 1980;133:287-92. (Pubitemid 10112732)
89. Wilson GN. Cranial defects in the Goldenhar syndrome. Am J Med Genet 1983;14:435-43. (Pubitemid 13108931)
90. Houdayer C, Portnoï MF, Vialard F, Soupre V, Crumière C, Taillemite JL, et al. Pierre Robin sequence and interstitial deletion 2q32.3-q33.2. Am J Med Genet 2001;102:219-26. (Pubitemid 32730269)
91. Dixon MJ. Treacher Collins syndrome. J Med Genet 1995;32:806-8.
92. Dixon MJ. Treacher Collins syndrome. Hum Mol Genet 1996;5:1391-6. (Pubitemid 26293898)
93. Edwards SJ, Gladwin AJ, Dixon MJ. The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am J Hum Genet 1997;60:515-24. (Pubitemid 27097599)
94. Dixon MJ, Read AP, Donnai D, Colley A, Dixon J, Williamson R. The gene for Treacher Collins syndrome maps to the long arm of chromosome 5. Am J Hum Genet 1991;49:17-22. (Pubitemid 21891648)
95. Arn PH, Mankinen C, Jabs EW. Mild mandibulofacial dysostosis in a child with a deletion of 3p. Am J Med Genet 1993;46:534-6. (Pubitemid 23172734)
96. Jabs EW, Coss CA, Hayflick SJ, Whitmore TE, Pauli RM, Kirkpatrick SJ, et al. Chromosomal deletion 4p15.32-p14 in a Treacher Collins syndrome patient: Exclusion of the disease locus from and mapping of anonymous DNA sequences to this region. Genomics 1991;11:188-92.
97. Marsh KL, Dixon J, Dixon MJ. Mutations in the Treacher Collins syndrome gene lead to mislocalization of the neucleolar protein treacle. Hum Mol Genet 1998;7:1795-800. (Pubitemid 28464155)